Fisetin for better walking and strength in breast cancer survivors
Treatments studied
Part of Cancer clinical trials.
This study tests whether fisetin (a natural compound) can improve physical function, like walking ability, in breast cancer survivors who feel frail. It may help strengthen muscles and improve daily activity after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through menopause before starting the study
- You have had breast cancer that is stage I–III and you are now a survivor (no active or returning cancer)
- You are currently frail, meaning you can walk less than 400 meters in a 6-minute walk test
- Your blood counts and organ function are high enough for safe study treatment (platelets, white blood cells, liver tests, kidney function, and hemoglobin)
- You can swallow pills and understand/sign the consent form
- You have not had chemo/biologic/immunotherapy in the last 30 days, and you have not had major surgery or radiation in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a supplement called fisetin to an exercise program can help prevent frailty in women who have finished chemotherapy for early-stage breast cancer. If you are postmenopausal, have completed chemo within the last year, and can walk a certain distance, you may qualify.
This study tests whether a natural supplement called fisetin can help slow lung decline in older adults who are either lifelong nonsmokers or long-term smokers. You would take fisetin or a placebo for a period and be monitored regularly.
This study tests whether a natural compound called fisetin can reduce fatigue in people aged 60+ who have completed cancer treatment. If you still feel tired often, this pill-based treatment might help you regain energy.
This Phase 2 trial tests whether fisetin, a supplement, can reduce frailty and inflammation in postmenopausal women age 70 and older. If it works, it may help older adults feel stronger and have healthier body signals related to aging and inflammation.
This trial studies whether fisetin, a supplement-like drug, can reduce frailty and inflammation in people age 70 and older. It may help improve health measures related to aging, but you must meet several safety and medication rules to join.
This study tests whether a supplement called fisetin can help reduce leg pain and improve walking ability in people with peripheral artery disease (PAD). If you have PAD and are 50 or older, you may be able to join and help see if fisetin can make walking easier.
Hear when a new Anatomic Stage I Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.